Market revenue in 2023 | USD 85.8 million |
Market revenue in 2030 | USD 199.3 million |
Growth rate | 12.8% (CAGR from 2023 to 2030) |
Largest segment | Alzheimer's disease |
Fastest growing segment | Alzheimer's Disease |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder |
Key market players worldwide | Qiagen NV, Abbott Laboratories, Merck & Co Inc, Johnson & Johnson, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Sysmex Corp, Merck KGaA, Roche Holding AG, Nimble Therapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunoassay for neurological biomarkers market will help companies and investors design strategic landscapes.
Alzheimer's disease was the largest segment with a revenue share of 35.78% in 2023. Horizon Databook has segmented the Mexico immunoassay for neurological biomarkers market based on alzheimer's disease, parkinson's disease, multiple sclerosis, autism spectrum disorder covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico holds significant share in the Latin American immunoassays for neurological biomarkers market as it represents an important market for exports to the U.S. Baja California and Tijuana states account for the highest exports.
According to the Medical Device Manufacturing in Mexico Whitepaper 2019 by Co-Production International, Inc., around 90 and 49 medical devices companies out of 740 were present in Baja California and Tijuana, respectively.
Moreover, around 92.5% of the total medical devices, including IVD products such as immunoassay analyzers manufactured in Tijuana, are exported to the U.S. Mexico has a Free Trade Agreement (FTAs) with many countries and provides government purchasing rules to such countries under Mexican law.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico immunoassay for neurological biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into Mexico immunoassay for neurological biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account